Home » Topics » Infection » Coronavirus

Coronavirus
RSS

Targeting Immunity, Not Invader, Key To Broad-Spectrum Antiviral

June 26, 2007

By Anette Breindl

Other News To Note

June 26, 2007

For Replikins, Replication Data Allow For Predicting Epidemics

April 27, 2006

By Jennifer Boggs

Other News To Note

Feb. 8, 2006

Other News To Note

Feb. 2, 2006

AVI Brings In $23M For Third-Generation Antisense Drugs

Nov. 16, 2005

Other News To Note

Nov. 3, 2005

Collaborations Between Biotech And Pharmaceutical Companies: Aug. 19-Oct. 19, 2005

Oct. 24, 2005

New SARS Target Discoveries;Fresh Therapeutic Approaches

Sep. 19, 2005

By Anette Breindl

Analysts: Interest In Antisense Waning, But Science Not Dead

Sep. 16, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2023.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 31, 2023.
Mbiomics raises €13M to pivot to microbiome-based therapeutic development
BioWorld
Mbiomics GmbH raised €13 million (US$14.2 million) in a first close of a series A round that will enable it to pivot from being a microbiome analytics firm to...
Bio-Europe Spring 2023: Despite funding woes, biotechs weather the storm with deals
BioWorld
Are deals such as M&As between biotechs and big pharma becoming a thing of the past? That was a key question posed during the opening keynote at this year’s...
Biohaven acquires early stage TYK2/JAK1 inhibitor from Highlightll in $970M deal
BioWorld
Biohaven Ltd. has acquired global rights, excluding China, from Highlightll Pharmaceutical Co. Ltd. to develop and commercialize a dual inhibitor of tyrosine...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.